s-nitroso-n-acetylpenicillamine has been researched along with Neointima in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flannery, WD; Jiang, Q; Kapadia, MR; Kibbe, MR; Oustwani, CS; Tsihlis, ND; Vavra, AK | 1 |
1 other study(ies) available for s-nitroso-n-acetylpenicillamine and Neointima
Article | Year |
---|---|
Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature.
Topics: Animals; Carotid Artery Injuries; Cells, Cultured; Disease Models, Animal; Dithiothreitol; Down-Regulation; Endopeptidases; Glutathione; Humans; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Nitric Oxide; Nitric Oxide Donors; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recombinant Proteins; S-Nitroso-N-Acetylpenicillamine; Time Factors; Ubiquitination; Vascular System Injuries | 2013 |